4.5
慢性閉塞性肺疾患I:はじめに
慢性閉塞性肺疾患は、持続的な症状と進行性の気流制限を特徴とする、一般的で予防可能かつ治療可能な呼吸器疾患です。この制限は、有害な粒子やガスへの曝露による慢性炎症によって引き起こされる小気道疾患(閉塞性気管支炎)と実質破壊(肺気腫)の組み合わせによるものです。
この疾患には主に2つの病理的要素があります…
慢性閉塞性肺疾患(COPD)は、一般的で予防可能かつ治療可能な肺疾患です。慢性的な呼吸器症状や気流制限があり、これらは通常、有害な粒子やガスへの長期曝露が慢性的な炎症や肺の損傷を引き起こします。
COPDでは、慢性炎症が気道や気嚢に持続的な変化を引き起こします。これらの変化には、気嚢に影響を与える肺気腫や、咳や過剰な粘液などの慢性気管支炎の兆候が含まれることがあります。
主なリスク要因には、タバコの煙、労働による粉塵や化学ガスへの曝露、換気の悪い住居での調理や暖房にバイオマス燃料を使用することによる室内大気汚染が含まれます。
追加リスクとしては、結核などの感染症や肺炎のような繰り返しの小児呼吸器感染症があります。
重要な遺伝的要因の一つがアルファ1抗トリプシン欠損症であり、これは肺がプロテオリゼン酵素に対抗する能力を低下させ、組織損傷を加速させ、早期発症COPDのリスクを高める状態です。
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic obstructive pulmonary disease?
COPD results from long-term exposure to harmful particles or gases causing chronic inflammation and lung damage. Major risk factors include tobacco smoke, occupational dust and chemical fumes, indoor air pollution from biomass fuels, and infections like tuberculosis or repeated childhood pneumonia. Genetic factors, particularly alpha-1 antitrypsin deficiency, also increase susceptibility to early-onset COPD.
Q2: How does chronic inflammation damage the lungs in COPD?
Chronic inflammation causes lasting structural changes in airways and air sacs. These changes include emphysema, which destroys alveolar walls and reduces elastic recoil, and chronic bronchitis, characterized by airway inflammation and excess mucus production. Together, these pathological processes limit airflow and impair gas exchange.
Q3: What is the difference between emphysema and chronic bronchitis in COPD?
Emphysema involves destruction of alveolar walls and loss of elastic recoil in air sacs. Chronic bronchitis is defined by chronic cough and sputum production due to airway inflammation and mucus hypersecretion. Although distinct in origin, these conditions often coexist in COPD patients and together contribute to airflow limitation.
Q4: Why is alpha-1 antitrypsin deficiency a genetic risk factor for COPD?
Alpha-1 antitrypsin is a protective enzyme that counteracts proteolytic enzymes in the lungs. Deficiency of this protein impairs the lungs' ability to defend against tissue-damaging enzymes, leading to accelerated lung damage and increased risk of early-onset emphysema even with minimal environmental exposure.
Q5: How do occupational and environmental exposures contribute to COPD development?
Long-term occupational exposure to dust such as silica and cotton, and chemical fumes, damages lung tissue over time. Indoor air pollution from biomass fuels in poorly ventilated homes and urban air pollution also increase COPD risk. These exposures accumulate gradually, leading to progressive lung damage and airflow limitation.
Q6: What role do early-life factors play in COPD susceptibility?
Early-life factors including recurrent respiratory infections, poor lung development from prematurity, and childhood asthma increase susceptibility to COPD later in life. These conditions may compromise initial lung development and function, making individuals more vulnerable to subsequent environmental exposures and chronic inflammation.
Q7: Is COPD preventable and treatable?
Yes, COPD is preventable and treatable. It is a common lung disorder characterized by persistent respiratory symptoms and airflow limitation. Prevention focuses on avoiding harmful exposures like tobacco smoke and occupational hazards, while treatment aims to manage symptoms and slow disease progression.